Intellectual Property | Fangda Partners

A US pharmaceutical company in a patent review matter before Beijing IP Court.
A US biotechnology company in patent infringement actions against generic drug companies.
A German pharmaceutical company in patent infringement actions against generic drug companies.
Astellas Pharma in a number of civil and administrative actions against infringing competitors.
Watson Pharmaceuticals in connection with its processing technology-related patent dispute with Eli Lilly, resulting in a final judgment in Watson Pharmaceutical’s favor rendered by the Supreme People’s Court of China.
APBI Holding in administrative litigation against Patent Reexamination Board of SIPO for the validity of its drug patent.
Aonuo Pharmaceuticals in a retrial before the Supreme Court in an invention patent infringement case brought by Hubei Wushi Pharmaceuticals.
Novartis International in patent disputes against generic companies.